Trials / Completed
CompletedNCT04389294
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Hospital for Special Surgery, New York · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | SARS-CoV2 serum antibody testing | Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other. |
Timeline
- Start date
- 2020-05-05
- Primary completion
- 2020-06-16
- Completion
- 2020-09-04
- First posted
- 2020-05-15
- Last updated
- 2024-01-03
- Results posted
- 2024-01-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04389294. Inclusion in this directory is not an endorsement.